Immunological reconstitution after autologous peripheral blood stem cell transplantation in patients with chronic lymphocytic leukemia.: Comparison with an historical non-Hodgkin's lymphoma group

被引：0
|
作者：
Laurenti, L [1 ]
Piccirillo, N [1 ]
Sorà, F [1 ]
Piccioni, P [1 ]
Tarnani, M [1 ]
Leone, G [1 ]
Sica, S [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Div Ematol, Rome, Italy
来源：
HAEMATOLOGICA | 2004年 / 89卷 / 01期
关键词：
immune recovery; hematologic reconstitution; chronic lymphocytic leukemia;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The kinetics of immune reconstitution after autologous peripheral blood stem cell transplantation (APBSCT) was examined in a group of 6 patients with chronic lymphocytic leukemia (CLL) and compared to that in an historical group of 12 patients with non-Hodgkin's lymphoma (NHL). Lymphocyte analysis included total lymphocyte count, CD3, CD4, CD8, CD4/8 ratio, CD19, and CD16/56 counts before, on day +15, +30, +60, +90, and +120 and 1 year after transplantation. Immunological recovery in the CLL group was similar to that in the NHL group.
引用
收藏
页码：120 / 122
页数：3
相关论文
共 45 条
  • [21] Clinical characteristics and treatment response in adult patients with chronic lymphocytic leukemia (CLL) and non Hodgkin's Lymphoma (NHL)
    Sicras-Mainar, Antoni
    Castro, Antonio
    Navarro-Artieda, Ruth
    GACETA MEDICA DE MEXICO, 2016, 152 (01): : 59 - 69
  • [22] Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma
    Pizzi, Marco
    Trentin, Livio
    Visentin, Andrea
    Saraggi, Deborah
    Martini, Veronica
    Guzzardo, Vincenza
    Righi, Simona
    Frezzato, Federica
    Piazza, Francesco
    Sabattini, Elena
    Semenzato, Gianpietro
    Rugge, Massimo
    HUMAN PATHOLOGY, 2019, 85 : 251 - 259
  • [23] Phase II study of palliative low-dose local radiotherapy in disseminated indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia
    Jóhannsson, J
    Specht, L
    Mejer, J
    Jensen, BA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (05): : 1466 - 1470
  • [24] Phase I/II study of 2-chloro-2′-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent. non-Hodgkin's lymphoma
    Van den Neste, E
    Louviaux, I
    Michaux, JL
    Delannoy, A
    Michaux, L
    Sonet, A
    Bosly, A
    Doyen, C
    Mineur, P
    André, M
    Straetmans, N
    Coche, E
    Venet, C
    Duprez, T
    Ferrant, A
    LEUKEMIA, 2000, 14 (06) : 1136 - 1142
  • [25] CAR T-Cell Therapy for B-Cell non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Clinical Trials and Real-World Experiences
    Vitale, Candida
    Strati, Paolo
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [26] The safety of bendamustine in patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma and concomitant renal impairment: a retrospective electronic medical record database analysis
    Nordstrom, Beth L.
    Knopf, Kevin B.
    Teltsch, Dana Y.
    Engle, Robert
    Beygi, Hooman
    Sterchele, James A.
    LEUKEMIA & LYMPHOMA, 2014, 55 (06) : 1266 - 1273
  • [27] The Concentration of CD44 Is Increased in Hematopoietic Stem Cell Grafts of Patients With Acute Myeloid Leukemia, Plasma Cell Myeloma, and Non-Hodgkin Lymphoma
    Krause, Daniela S.
    Spitzer, Thomas R.
    Stowell, Christopher P.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2010, 134 (07) : 1033 - 1038
  • [28] Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611)
    Tallarico, Michael
    Foster, Jared C.
    Seisler, Drew
    Lafky, Jacqueline M.
    Hurria, Arti
    Jatoi, Aminah
    Cohen, Harvey J.
    Muss, Hyman B.
    Bartlett, Nancy
    Cheson, Bruce D.
    Jung, Sin-Ho
    Leonard, John P.
    Byrd, John C.
    Nabhan, Chadi
    JOURNAL OF GERIATRIC ONCOLOGY, 2018, 9 (04) : 321 - 328
  • [29] Decreased dickkopf-1 levels in chronic lymphocytic leukemia and increased osteopontin levels in non-Hodgkin's lymphoma at initial diagnosis: Could they be playing roles in pathogenesis?
    Pamuk, Gulsum Emel
    Uyanik, Mehmet Sevki
    Pamuk, Omer Nuri
    Maden, Muhammet
    Tapan, Umit
    HEMATOLOGY, 2015, 20 (05) : 267 - 271
  • [30] High-dose Thiotepa, Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation as Upfront Consolidation for Systemic Non-Hodgkin Lymphoma With Synchronous Central Nervous System Involvement
    Qualls, David
    Sullivan, Andrew
    Li, Shuli
    Brunner, Andrew M.
    Collier, Kerry
    Hochberg, Ephraim
    Armand, Philippe
    Batchelor, Tracy T.
    Chen, Yi-Bin
    DeFilipp, Zachariah
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (12) : 884 - 888
12345